Global Sumatriptan Succinate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sumatriptan Succinate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sumatriptan is used to treat acute migraine headaches in adults. It is not used to prevent migraine headaches and is not used for cluster headaches. Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.
Global Sumatriptan Succinate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital Pharmacies and Drug Stores are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sumatriptan Succinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sumatriptan Succinate key manufacturers include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck and Sun Pharmaceutical, etc. GlaxoSmithKline, Pfizer, Teva are top 3 players and held % sales share in total in 2022.
Sumatriptan Succinate can be divided into Tablet, Subcutaneous Injection and Nasal Spray,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Sumatriptan Succinate is widely used in various fields, such as Hospital Pharmacies and Drug Stores, etc. Hospital Pharmacies provides greatest supports to the Sumatriptan Succinate industry development. In 2022, global % sales of Sumatriptan Succinate went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sumatriptan Succinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
Segment by Type
Tablet
Subcutaneous Injection
Nasal Spray
Hospital Pharmacies
Drug Stores
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Sumatriptan Succinate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sumatriptan Succinate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sumatriptan Succinate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sumatriptan Succinate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sumatriptan Succinate introduction, etc. Sumatriptan Succinate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sumatriptan Succinate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global Sumatriptan Succinate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital Pharmacies and Drug Stores are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sumatriptan Succinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sumatriptan Succinate key manufacturers include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck and Sun Pharmaceutical, etc. GlaxoSmithKline, Pfizer, Teva are top 3 players and held % sales share in total in 2022.
Sumatriptan Succinate can be divided into Tablet, Subcutaneous Injection and Nasal Spray,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Sumatriptan Succinate is widely used in various fields, such as Hospital Pharmacies and Drug Stores, etc. Hospital Pharmacies provides greatest supports to the Sumatriptan Succinate industry development. In 2022, global % sales of Sumatriptan Succinate went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sumatriptan Succinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
Segment by Type
Tablet
Subcutaneous Injection
Nasal Spray
Segment by Application
Hospital Pharmacies
Drug Stores
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Sumatriptan Succinate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sumatriptan Succinate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sumatriptan Succinate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sumatriptan Succinate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sumatriptan Succinate introduction, etc. Sumatriptan Succinate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sumatriptan Succinate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices